Drug Shortage Report for POTASSIUM ACETATE INJECTION USP

Last updated on 2024-10-01 History
Report ID 237160
Drug Identification Number 02362597
Brand name POTASSIUM ACETATE INJECTION USP
Common or Proper name POTASSIUM ACETATE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) POTASSIUM ACETATE
Strength(s) 39.2%
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 50mL vial / fiole
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2024-09-13
Actual start date 2024-09-20
Estimated end date 2024-12-15
Actual end date
Shortage status Actual shortage
Updated date 2024-10-01
Company comments Sodium Acetate, which can be used as a substitute for Potassium Acetate, is also available at CPDN and Omega.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-10-01 French Compare
v11 2024-10-01 English Compare
v10 2024-09-23 French Compare
v9 2024-09-23 English Compare
v8 2024-09-23 English Compare
v7 2024-09-21 English Compare
v6 2024-09-20 French Compare
v5 2024-09-20 English Compare
v4 2024-09-14 English Compare
v3 2024-09-10 French Compare
v2 2024-09-10 English Compare
v1 2024-09-10 English Compare

Showing 1 to 12 of 12